; 42 U.S.C. 282 note) is amended by striking 2013 through 2017 and inserting 2018 through 2022 . 505. Reauthorization of orphan grants program Section 5(c) of the Orphan Drug Act ( 21 U.S.C. 360ee(c) ) is amended by striking 2013 through 2017 and inserting 2018 through 2022 . 506. Reauthorization of inspection program Section 704(g)(11) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 374(g)(11) ) is amended by striking October 1, 2017 and inserting October 1, 2022 . 507. Reauthorization of pediatric study of drugs Section 409I(e)(1) of the Public Health Service Act ( 42 U.S.C. 284m(e)(1) ) is amended by striking 2013 through 2017 and inserting 2018 through 2022 . VI Additional Provisions 601. Technical corrections (a) Section 3075(a) of the 21st Century Cures Act ( Public Law 114–255 ) is amended— (1) in the matter preceding paragraph (1), by striking as amended by section 2074 and inserting as amended by section 3102 ; and (2) in paragraph (2), by striking section 2074(1)(C) and inserting section 3102(1)(C) . (b) Section 506G(b)(1)(A) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 356g(b)(1)(A) ) is amended by striking identity and inserting identify . (c) Section 505F(b) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355g(b) ) is amended by striking randomized and inserting traditional . (d) Section 505F(d) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355g(d) ) is amended by striking 2 and inserting 3 . (e) Effective as of the enactment of the 21st Century Cures Act ( Public Law 114–255 )— (1) section 3051(a) of such Act is amended by striking by inserting after section 515B and inserting by inserting after section 515A